1 |
Black MM. (1977). Immunopathology of breast cancer. Pathobiol Annu, 7, 213-30
|
2 |
Farhad RR, Soheila A, Ramesh O, et al (2015). Comparative analysis of CD4 ,CD8 T cells in tumor tissue, lymph nodes and peripheral blood from patients with breast cancer. Iranian B j 19, 35-44.
|
3 |
Liyange UK, Moree TT, Joo HG et al (2002). Prevalence of regulatory T cells is inceased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol, 169, 2756-61.
DOI
|
4 |
Macchetti AH, Marana HRC, Silva JS, et al (2006). Tumor infiltrating CD4 T lymphocytes in early cancer reflect lymph node involvement. Cliinics, 61, 203-8.
|
5 |
Mahmoud SM, Paish EC, Powe DG, et al (2011). Tumor infiltrating CD8 lymphocytes predict clinical outcome in breast cancer. J Clinc Oncol, 29, 1949-55.
DOI
|
6 |
Vagenopoulo S, Lazaris AC, Markopolus C, et al (2003). Immunohistochemical evaluation of immune response in invasive ductal breast cancer of not-otherwise = specified type. Breast, 12, 172-8.
DOI
|
7 |
Warne ET, Tamimi RM, Hughes ME, et al (2014). Racial and ethnic differences in breast cancer survival. J Clin Oncol, 33, 2254-61.
|
8 |
Westermann J, Pabst R (1990). Lymphocyte subsets in the blood: a diagnostic window on the lymphoid system. Immunol Today, 11, 406-10.
DOI
|
9 |
Yo-Ping L, Chung-Jiuan J, Shu-ching C (2011). The roles of CD4 T cell in tumor immunity. J Immunol, 6, 65-72.
|